LANCE NASON: Open Payments
NPI 1396417150 · BONNERS FERRY, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$142 in 8 payments from 6 companies in 2025. Trend: 2023 $172 · 2024 $180 · 2025 $142
Food & beverage: $142
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
Products named: REXULTI, JARDIANCE, INGREZZA, Rybelsus, COBENFY, MOUNJARO.
Industry payments across ID — which companies pay providers there.
